Literature DB >> 25749337

Caloric restriction mimetic 2-deoxyglucose alleviated lethal liver injury induced by lipopolysaccharide/D-galactosamine in mice.

Qian Che1, Ling Lin1, Qing Ai2, Pu Ge1, Jie Dai3, Rong Jiang4, Dan Zhou1, Jingyuan Wan5, Li Zhang6.   

Abstract

The glycolytic inhibitor 2-deoxyglucose (2-DG) is a calorie restriction (CR) mimetic produces CR-like beneficial effects in both acute and chronic pathological processes, but whether 2-DG is also helpful in critical and life-threatening situation is not known. In the present study, the potential benefits of 2-DG in lipopolysaccharide/D-galactosamine (LPS/D-Gal)-induced lethal liver injury were investigated. The results indicated that treatment with 2-DG suppressed the elevation of plasma aminotransferases, alleviated the histopathological abnormalities and improved the survival rate of LPS/D-Gal-exposed mice. Treatment with 2-DG also suppressed the production of pro-apoptotic cytokine TNF-α, the phosphorylation of JNK, the activation of caspase cascade and the count of TUNEL-positive apoptotic hepatocytes. These data suggested that the CR mimetic 2-DG could also provide beneficial effects in lethal pathological process such as LPS/D-Gal-induced fulminant liver injury.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-Deoxyglucose; Calorie restriction mimetic; Lipopolysaccharide; Liver injury

Mesh:

Substances:

Year:  2015        PMID: 25749337     DOI: 10.1016/j.bbrc.2015.02.145

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  AMPK activation does not enhance autophagy in neurons in contrast to MTORC1 inhibition: different impact on β-amyloid clearance.

Authors:  Irene Benito-Cuesta; Lara Ordóñez-Gutiérrez; Francisco Wandosell
Journal:  Autophagy       Date:  2020-02-20       Impact factor: 16.016

2.  Caloric Restriction Mimetic 2-Deoxyglucose Alleviated Inflammatory Lung Injury via Suppressing Nuclear Pyruvate Kinase M2-Signal Transducer and Activator of Transcription 3 Pathway.

Authors:  Kai Hu; Yongqiang Yang; Ling Lin; Qing Ai; Jie Dai; Kerui Fan; Pu Ge; Rong Jiang; Jingyuan Wan; Li Zhang
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.